A quarter of people with HCV initially refused access to sofosbuvir/lepidasvir

A quarter of people with HCV initially refused access to sofosbuvir/lepidasvir … Treatment of HCV infection has been revolutionised by the development of direct-acting antiviral (DDA) agents. Compared to traditional therapy with pegylated interferon/ribavirin, treatment with DDAs is associated with … Continue reading

Egyptian doctors given 'contamination allowance' for the risk of contracting

Egyptian doctors given 'contamination allowance' for the risk of contracting … The current allowance is about 15-30 EGP, the syndicate said, and doctors are the most exposed to contagious diseases, especially respiratory diseases, blood diseases and Hepatitis C, which led … Continue reading

Biotron develops combined HIV-1 and HCV treatment

Biotron develops combined HIV-1 and HCV treatment Biotron Limited, which develops innovative treatments for viral diseases that have unmet medical needs, recently released information about its leading drug, a combined treatment for HIV-1 and Hepatitis C virus (HCV). BIT225 shows … Continue reading